Mirati Ther Financials

Mirati Ther Stock Summary

Mirati Ther competes with Sarepta Therapeutics, Krystal Biotech, Day One, Amylyx Pharmaceuticals, and Terns Pharmaceuticals. Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Mirati Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people.

Mirati Ther Key Financial Ratios

Mirati Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mirati Ther's current stock value. Our valuation model uses many indicators to compare Mirati Ther value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mirati Ther competition to find correlations between indicators driving Mirati Ther's intrinsic value. More Info.Mirati Ther is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mirati Ther's earnings, one of the primary drivers of an investment's value.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.